Meningococcal disease: public health burden and control.
about
Prospects for vaccine prevention of meningococcal infectionEndotoxin of Neisseria meningitidis composed only of intact lipid A: inactivation of the meningococcal 3-deoxy-D-manno-octulosonic acid transferase.Infections of People with Complement Deficiencies and Patients Who Have Undergone SplenectomyFit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitisMolecular epidemiology of serogroup a meningitis in Moscow, 1969 to 1997.Large-scale analysis of the meningococcus genome by gene disruption: resistance to complement-mediated lysis.Mutagenesis of Neisseria meningitidis by in vitro transposition of Himar1 mariner.Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana.A phase II, randomized study on an investigational DTPw-HBV/Hib-MenAC conjugate vaccine administered to infants in Northern Ghana.Meningococcal disease and climate.Evaluation of the enhanced meningitis surveillance system, Yendi municipality, northern Ghana, 2010-2015.The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology.A Licensed Combined Haemophilus influenzae Type b-Serogroups C and Y Meningococcal Conjugate Vaccine.Mutator clones of Neisseria meningitidis in epidemic serogroup A diseaseEvaluation of recombinant lipidated P2086 protein as a vaccine candidate for group B Neisseria meningitidis in a murine nasal challenge model.Induction of protective serum meningococcal bactericidal and diphtheria-neutralizing antibodies and mucosal immunoglobulin A in volunteers by nasal insufflations of the Neisseria meningitidis serogroup C polysaccharide-CRM197 conjugate vaccine mixedInvasive meningococcal disease in Scotland, 1994 to 1999, with emphasis on group B meningococcal disease.The conformational properties of methyl alpha-(2,8)-di/trisialosides and their N-acyl analogues: implications for anti-Neisseria meningitidis B vaccine designRestoration of Akt activity by the bisperoxovanadium compound bpV(pic) attenuates hippocampal apoptosis in experimental neonatal pneumococcal meningitis.Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine.The meningococcus tamed?Significant sequelae after bacterial meningitis in Niger: a cohort study.Neisseria meningitidis RTX proteins are not required for virulence in infant rats.Neisseria meningitidis C:2b:P1.2,5 with intermediate resistance to penicillin, PortugalMeningococcal disease in Asia: an under-recognized public health burdenStructurally identical capsular polysaccharide expressed by intact group B streptococcus versus Streptococcus pneumoniae elicits distinct murine polysaccharide-specific IgG responses in vivoAetiological agents of cerebrospinal meningitis: a retrospective study from a teaching hospital in Ghana.Relationships between climate and year-to-year variability in meningitis outbreaks: a case study in Burkina Faso and NigerMobile microbiological laboratory support for evaluation of a meningitis epidemic in Northern Benin.Clonal groupings in serogroup X Neisseria meningitidis.Airborne dust and high temperatures are risk factors for invasive bacterial disease.Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae, a review
P2860
Q24537338-C7280A69-B60C-464D-B02B-ED479AC86388Q24538929-5A423600-4103-4CE1-97F5-C84BEA151CA9Q28972389-7F4C817C-C52B-4BA9-818C-04CE89A932C4Q30328085-90E7694C-308D-4877-A35C-09636AD21BAFQ30328266-DA6C23A7-2BB7-47D5-8D1D-E3617C2AF3B9Q30891451-01EBFA86-5720-418B-B43D-6DC0F8C79912Q30924793-6BEFB1C9-9A3D-46C5-9D24-7ED1DC01D0C7Q33280136-580B80AA-8989-4F00-AF57-525DECE81D20Q33334377-07EB9993-9AED-4446-B577-AA602654A6E1Q33561983-30A3CD4E-B6E3-4FC4-A682-D76BE4F06F90Q33601046-41A589C4-66FA-4B70-861D-004ED7423A8AQ33610843-93E9F35F-7191-416E-A673-41F47D6E1612Q33939014-02396B1A-C628-4B40-91B0-C1592B19B2D0Q34028018-F3C5A1D3-457B-4257-9065-8E9608E2825DQ34033214-0A28C9C4-79C7-4F08-9CC1-09C0480E3E10Q34194667-CAE1FB0D-6EEF-4AC6-8C40-D018EBEFA022Q34202591-913C81B1-BE71-4562-84B7-80297BDDFEACQ34211831-2CD90F97-AC8A-4631-9265-AC41ACAB90E5Q34316072-76CC6EF5-0933-4BFE-AB3B-E49826E68889Q34430626-73967157-360D-41F8-8222-D77143C2FCD3Q34712881-BADF81CD-1F0D-4C78-B024-06DB90A4337BQ34728780-3F86FE02-FF68-4E2F-95C0-31499F1187F4Q34856191-B41581F8-2022-4BE1-8F5E-1E6970187B20Q34907381-4E714631-694D-4957-80A6-4657C1C8D3EFQ35017972-7FFF8B1C-BB94-484E-A0C0-5000E89F09A2Q35980776-AED51E91-8E28-4BCD-91A1-840C7A350E82Q36323310-2355DEC6-EBA9-4CA6-8E06-C09CBEB26223Q36824332-C966C623-2169-4431-B1C2-ACF4BC1BB23BQ36976418-A4B0D478-0268-405F-AC36-0543B805A556Q37320175-F8C50D2F-3CB4-4963-A498-EF72CFC0BDD0Q37682719-7A2D180C-6FA8-4CC4-AD9F-D171B92C871EQ37693513-1AB11D70-8B81-4087-96BA-C8E714517E31
P2860
Meningococcal disease: public health burden and control.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Meningococcal disease: public health burden and control.
@ast
Meningococcal disease: public health burden and control.
@en
type
label
Meningococcal disease: public health burden and control.
@ast
Meningococcal disease: public health burden and control.
@en
prefLabel
Meningococcal disease: public health burden and control.
@ast
Meningococcal disease: public health burden and control.
@en
P2093
P1476
Meningococcal disease: public health burden and control.
@en
P2093
Santamaria M
Tikhomirov E
P304
P577
1997-01-01T00:00:00Z